Various Hypo-RESOLVE members will be featuring at the EASD conference taking place in Stockholm from 19-23 September 2022. Take a look at their contributions in this special Hypo-RESOLVE EASD program...

The Hypo-RESOLVE consortium is proud to announce that a paper has been published on the Hypo-METRICS study protocol in Diabetic Medicine, namely

Hypo-METRICS: Hypoglycaemia—MEasurement, ThResholds a...

It’s a wrap: We would like to thank all Hypo-RESOLVE speakers and participants for presenting our research at the scientific sessions at ADA 2022 in New Orleans - we had a blast. We would like to prov...

The Hypo-RESOVLE consortium is very pleased to announce that the IMI approved an 18 months’ no-cost extension of the Hypo-RESOLVE action end of April 2022. The project will now terminate in October 20...

On 15th March 2022, the Hypo-RESOLVE Managing Board gathered online to discuss the action’s progress and plan work for the no-cost project extension, which has been requested with the IMI2 JU to allow...

Making sure that the Hypo-RESOLVE results change the diabetes (research) landscape for the better, is one of our most important goals. For our last episode, we have invited Jens Heisterberg from Novo...

Patient-Reported Outcome (PRO) Measures reliably assess the psychological impact of hypoglycaemia. Our seventh episode features researchers Dr Jill Carlton and Dr Philip Powell from the University of...

Diabetes and hypoglycaemia extend beyond physical effects and can become a psychological burden as well. Today’s episode features Melanie Broadley from the University of Southern Denmark and Renza Sci...

What are the implications of hypoglycaemic episodes that are underneath the detection threshold of current glucose measuring devices? This is what the Hypo-METRICS study set out to determine. Our podc...

On 11th February, the International Day of Woman & Girls in Science, Hypo-RESOLVE researchers joint in celebrating the Women in Science Day’s twitter campaign.

A great thank you to Judit Castillo ...

Today’s fourth episode marks the halfway point of our podcast series – thank you for tuning in so far! We have invited special guests Professor Simon Heller from the University of Sheffield and Renza...

In today’s episode, we are talking data and a lot of it! Mark Ibberson from SIB and Laura Cooke from our Patient Advisory Committee (PAC) talk about the challenge of bringing together a lot of clinica...

Our second podcast episode is bringing you an important topic: Professor Rory McCrimmon from the University of Dundee and Laura Cooke from our Patient Advisory Committee (PAC) discuss the effects and...

We are proud to introduce our brand-new Hypo-RESOLVE podcast series: “Patient Engagement in Research Initiatives: The Hypo-RESOLVE Approach”.

In this eight-episode series, we are shining a light...

The Hypo-RESOLVE consortium sends season’s greetings and best wishes for the new year to everybody contributing to the project or supporting Hypo-RESOLVE by following us either here or on Twitter. Tha...

Hypo-RESOLVE partner IDF (International Diabetes Federation) has published the 10th Edition of the IDF Diabetes Atlas providing the latest overview on the global impact of Diabetes with updated nati...

Today, 14th November, is the official World Diabetes Day. As every year, Hypo-RESOLVE joins by launching a dedicated twitter campaign. This year’s motto is “Access to Diabetes Care – If Not Now, When?...

The Hypo-RESOLVE consortium is pleased to announce that the publication "The impact of hypoglycaemia on quality of life outcomes among adults with type 1 diabetes: a systematic review", led by partn...

The Hypo-RESOLVE consortium again had to succumb to the COVID-19 pandemic and gathered online to hold its Annual Meeting 2021, since various consortium members were still not allowed to travel and cur...

The Hypo-RESOLVE consortium is happy to announce that the EC accepted its 3rd progress report covering the achievements of the third year in Hypo-RESOLVE. Although strongly overshadowed by the COVID-1...

Blog post by Hannah Chatwin

Hypoglycaemia (or hypo) occurs when blood glucose drops too low. This is a common side effect of insulin treatment. Symptoms include sweating, trembling, confusion, and s...

On 6th May 2021, the Hypo-RESOLVE Managing Board gathered remotely to not only discuss progress achieved over the past months and to plan next steps, but also to start first discussions regarding a pr...

The Hypo-RESOLVE consortium is happy to announce the release of its new animated clip. The video illustrates the project’s pathway towards providing further research evidence about hypoglycaemia to al...

On 10th February 2021, the Hypo-RESOLVE Managing Board convened virtually to discuss progress achieved over the past couple of months. Notable achievements, amongst others, were the start of recruitme...

On 11th February, the International Day of Woman & Girls in Science, Hypo-RESOLVE women researchers joint in celebrating the Women in Science Day’s twitter campaign. A great thank you to Mari-Anne ...

The Hypo-RESOLVE consortium is proud to announce that two papers have been published in Diabetologia, namely

• “The suitability of patient-reported outcome measures used to assess the impact of hypog...

On 29th October, Hypo-RESOLVE Managing Board met remotely with the IMI and four external experts for the official project’s Midterm Review. After a warm welcome by our Project Officer Magda Gunn, Proj...

With the upload of data from more than 100 clinical trials comprising almost 60.000 individuals completed, Hypo-RESOLVE has taken a great step towards the creation of a secure, sustainable database. P...

The Hypo-RESOLVE Consortium is pleased to communicate that on 24th September 2020 the IMI published The constant threat of 'hypos' takes a heavy toll on people with diabetes based on a Q&A interview...

The Hypo-RESOLVE consortium is very pleased to announce that the EC accepted its 2nd progress report covering the achievements of the second year in Hypo-RESOLVE. During those twelve months, considera...

On 21st September 2020, the Hypo-RESOLVE Managing Board met virtually to present work progress, discuss future steps and also evaluate the impact the COVID-19 pandemic is having on the project’s progr...

Originally scheduled to take place in Wiesbaden, Germany, from 13-14 May 2020, the Hypo-RESOLVE Annual Progress Meeting 2020 had to be reorganised as a web meeting in face of the COVID-19 pandemic. Ow...

On 4th February 2020, the Managing Board of Hypo-RESOLVE met for its fifth face-to-face meeting at Frankfurt Airport. Besides presenting updates on their progress and first results from different Work...

Paper on our work accepted by Diabetic Medicine

An extremely successful Hypo-RESOLVE work package 2 (WP2) face-to-face meeting was held in Copenhagen on January 17 with representatives from almost all partners participating. The full day meeting st...

The Hypo-RESOLVE consortium is very pleased to announce that the EC accepted its 1st progress report covering the achievements of a very exciting first year. During the initial twelve months of the pr...

Data upload completed for 71 out of >100 trials

On 15th of September 2019, the Managing Board of Hypo-RESOLVE met for its fourth face-to-face meeting linked to the 55th Annual Meeting of the EASD in Barcelona. The members of the Managing Board pres...

Make use of your chance to influence future objectives for EU-funded research and innovation which will contribute to the “strategic plan” and priorities of Horizon Europe’s first four years (2021-202...

The University of Sheffield is offering an online course on 'Measuring and Valuing Health' starting on 8 July 2019

Blogpost by our member Renza Scibilia on the importance of involving people with diabetes in the Hypo-RESOLVE project

The Hypo-RESOLVE consortium met for its 1st Annual Progress Meeting from May 08-10, 2019 in Nijmegen, The Netherlands, at the Radboud University Medical Centre (RUMC), Coordinator in this IMI2 JU publ...

On March 11, the Hypo-RESOLVE Managing Board met near Frankfurt/Main for its third face-to-face meeting. After almost one year ino the project, all Work Package Leads were eager to present their parti...

On November 20, the Hypo-RESOLVE Managing Board met in the Netherlands for its second face-to-face meeting. Six months into the project, all Work Package Leads were enthusiastic to report about a smoo...

Registration is open for the IMI 10th Anniversary Scientific Symposium, which will be held in Brussels on 22 and 23 October 2018 (before the Stakeholder Forum). The event will feature more than 70 pos...

During it’s Kick-Off Meeting in Denmark, Hypo-RESOLVE researchers had the opportunity to speak about their involvement in the project, about the overall aim of Hypo-RESOLVE and the impact on people li...

Hypo-RESOLVE project partners Novo Nordisk and KCL are advertising a postdoctoral researcher position – what you’d need to join the team is experience in biostatistics and diabetes modelling – and of...

WP6 leads of the Hypo-RESOLVE consortium invite suitably qualified contract research organisations or academic groups to submit a proposal for the supply of a series of high quality systematic literat...

After preparing the grant applications for 1.5 years, the Hypo-RESOLVE consortium was in great anticipation of the day that would launch the project activities officially. From May 16-17, 2018, the wh...

The international consortium aims to provide evidence-based classification of hypoglycaemia to achieve better treatments for people living with diabetes